Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients
Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients
About this item
Full title
Author / Creator
Publisher
United States: Mary Ann Liebert, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Mary Ann Liebert, Inc
Subjects
More information
Scope and Contents
Contents
The primary objectives of this study were to evaluate the pharmacokinetics (PK) and tolerability of single and multiple doses of vortioxetine in children and adolescents with a depressive or anxiety disorder and to provide supportive information for appropriate dosing regimens for pediatric clinical trials.
This prospective, open-label, multinat...
Alternative Titles
Full title
Pharmacokinetics and Safety of Vortioxetine in Pediatric Patients
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5568018
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5568018
Other Identifiers
ISSN
1044-5463
E-ISSN
1557-8992
DOI
10.1089/cap.2016.0155
